Today’s AI Top Pick: PODD
7/16/2026 · Recently Alerted GARP screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live PODD price forecast →
PODD is the cleanest multi-timeframe setup in the pool with the least amount of chase risk. The daily forecast is stacked (+10.95% short / +51.33% mid / +63.17% long), the 4h confirms with +19.91% mid / +53.41% long, and the weekly turns constructive from a deeply washed-out base (+34.4% mid / +53% long) after a -35.41% 21-bar weekly draw and a -43.96% YTD. Near-term bullish score is a perfect 1.0, bullish_prob = 1, fundamental_score = 8. Crucially, the weekly pos_in_range is only 14.1 and 4h is 47.92 — so despite a strong daily (79.62), you're buying a name that's still deeply mean-reverting on the longer frames rather than chasing a breakout. The fundamentals are exactly what a GARP screener wants to reward: fwdPe 19.78, PEG 0.74, ROE 23%, salesYoY 31.93%, epsNextY 24.34%, profitMargin 10.44%, debt/eq only 0.73, analyst recom 1.44, and 47.5% target upside. This is real growth at a reasonable price, not a story stock. Compare that to HSAI (PE 283, thinner margins), CRK (had a Q1 miss, called out as cash-burning), or FUTU (DOJ probe + class actions — an outright landmine even though the forecast tape looks great). News confirms rather than undercuts the thesis: today's ChartMill piece explicitly frames PODD as "A Quality Affordable Growth Stock With Strong Earnings Momentum," and the Calm partnership plus the 8.9% CAGR industry note on continuous glucose monitoring are all constructive. There are no guidance cuts, dilution, regulatory issues, or short-seller reports. The tape is confirming a bottoming pattern in a name that's already down 44% YTD — you're not paying up. Waiting doesn't help here: daily dd_from_21bar_high is only -3.16% and pos_in_range on daily is 79.62, but the 4h has already digested that (pos 47.92, dd -4.57) and the weekly is at 14.1 of range. Effectively, the intraday timeframes have absorbed the near-term move and the higher timeframes still have massive room. The forecasted +51% mid / +63% long on the daily, if even half-realized, prints ~$200-$240. Entry today at $159 with a stop under $150 gives ~2:1 to the first target and 3-5:1 to the longer target.
- Daily pos_in_21bar_range is 79.62% — a hot open could give a better fill after a 2-3% flush
- Insulin pump competition (CGM/pump convergence): if a competitor announces a favorable product cycle, PODD's premium can compress fast
- Stock is -45.07% YoY and -43.96% YTD — this is a broken-then-repairing chart, not a leader; a market-wide risk-off can rip the base
- 1h forecast is actually negative (-8.47% short / -4.74% mid) — expect near-term chop before the daily/weekly thesis plays out
- Healthcare medical-device names carry binary regulatory/reimbursement headline risk
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | PODD | BUY NOW | 8.7 | Multi-TF alignment, fundamental_score 8, deep weekly base (pos 14.1), positive news, forecast +51%/+63% mid/long on daily. |
| 2 | HSAI | BUY NOW | 8.2 | Best entry among the growth names (1d pos 33, 4h pos 11) with +27/+49/+42 forecast and positive stock-split catalyst. |
| 3 | CELH | BUY NOW | 7.8 | Explosive daily forecast +31/+48/+54, salesYoY 123%, 4h still mid-range, positive brand/valuation coverage. |
| 4 | BILI | BUY PULLBACK | 7.5 | Daily +15/+39/+32 with $300M buyback catalyst, but pos_in_range 100 on 1d — wait for a dip. |
| 5 | ORCL | BUY NOW | 7.3 | RSI 30.42 oversold, 1d fc +32/+48 mid/long, 92% target upside, 'stock could double by 2028' catalyst; 1wk still negative is the caveat. |
| 6 | PDD | BUY PULLBACK | 7.2 | fwdPe 6.95, ROE 25.5%, strong forecast +17/+28/+27; pos_in_range 100 on 1d says wait a day or two. |
| 7 | AGI | BUY NOW | 7.1 | Peter Lynch GARP piece today, PEG 0.23, 4h fc +30/+38, RSI 34.9 oversold, entry at bottom of range. |
| 8 | HURN | BUY NOW | 6.9 | Daily +7.77/+22.55/+29.17, near_term_bullish 1, recom 1.0, 44% undervalued call; weekly forecast is the concern. |
| 9 | NRDS | BUY PULLBACK | 6.7 | PEG 0.28, fwdPe 8.32, 1d fc +15%/+15% mid/long; but SeekingAlpha downgrade on 'worsening economics' is a caution. |
| 10 | CALX | BUY NOW | 6.6 | Daily +8.85/+30/+34, weekly still in lower half (pos 24), earnings next week catalyst. |
| 11 | STEP | BUY PULLBACK | 6.5 | 1d fc +5/+23/+24, salesYoY 70%, but negative ROE and price-target trims muddy the picture. |
| 12 | FUTU | WAIT | 6.4 | Beautiful daily forecast (+50/+57/+44) but DOJ probe + class actions is a genuine landmine; weekly fc negative. |
| 13 | MSFT | BUY PULLBACK | 6.3 | Fundamentals bulletproof (ROE 34, margin 39%) but daily/4h at pos 100 and 1wk fc negative — chase risk. |
| 14 | KKR | BUY PULLBACK | 6.2 | Solid fundamentals, but pos_in_range 100 across 4h/1d and weekly fc -3/-5/-6; entry too late. |
| 15 | SRAD | BUY PULLBACK | 6.1 | PEG 0.48, epsNextY 69.71%, 1d fc +3/+36/+34; JPM PT raise helpful, but 1h forecast negative. |
| 16 | NOW | BUY PULLBACK | 6.0 | Strong daily forecast (+11/+18/+30) but 1h/4h negative and Simply Wall St flagged premium after 76% fall. |
| 17 | SE | WAIT | 5.9 | RSI 71.7, 4h/1h forecasts sharply negative (-19 to -22), COO insider sale flagged; overheated. |
| 18 | ONON | WAIT | 5.8 | near_term_bullish 0.0, 1h pos_in_range 0, JPM Overweight resumption is nice but tape isn't confirming. |
| 19 | PFSI | BUY PULLBACK | 5.7 | PE 9, PEG 0.33, decent forecast; Barclays downgrade caps the edge, targetUpside only 20.7%. |
| 20 | TOST | WAIT | 5.6 | RSI 69.5, pos_in_range 100 on 1d/1wk, 1h/4h forecasts sharply negative (-10 to -20); classic chase trap. |
| 21 | SAP | BUY PULLBACK | 5.5 | Quality growth, targetUpside 59.5%, but near_term_bullish not shown in candidate block; RSI 43 fine. |
| 22 | DCBO | BUY PULLBACK | 5.4 | 1wk fc +68/+104 is eye-popping but near_term_bullish only 0.2 and 1h/4h pos_in_range near 0 — wait for turn. |
| 23 | MLCO | BUY PULLBACK | 5.3 | Weekly fc +20/+42/+51 attractive, cheap fwdPe 7.64; MS downgrade is the offset. |
| 24 | SMCI | WAIT | 5.1 | 1d fc +32/+39 tempting but shortFloat 18.3, recom 3.0, GM only 8.4% — high-variance name. |
| 25 | STVN | BUY PULLBACK | 5.0 | TD Cowen Buy init, decent GARP; bullish_prob only 0.8 and PEG 1.38 is highest in the pool. |
| 26 | ITRG | WAIT | 4.8 | PEG 0.10 optically insane but weekly fc -15/-23/-38 and pos_in_range 0 across 1d/1wk — falling knife. |
| 27 | EQX | WAIT | 4.7 | 1wk fc -11/-30/-39 outright bearish and daily pos_in_range 0; gold miner in a downtrend. |
| 28 | CRK | WAIT | 4.5 | Great daily forecast (+21/+55/+52) but StockStory flagged as 'cash-burning' and Q1 miss; recom 2.76 weakest. |
| 29 | FRSH | AVOID | 4.3 | bullish_prob 0.6, targetUpside only 10.7%, 1h/4h forecasts negative, StockStory 'we ignore' framing. |
| 30 | HUBS | AVOID | 4.0 | PE 113, op margin 2%, 1wk perf -46%, 'slower demand' narrative — broken growth story. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord